183 related articles for article (PubMed ID: 25159481)
1. Linking ATM Promoter Methylation to Cell Cycle Protein Expression in Brain Tumor Patients: Cellular Molecular Triangle Correlation in ATM Territory.
Mehdipour P; Karami F; Javan F; Mehrazin M
Mol Neurobiol; 2015 Aug; 52(1):293-302. PubMed ID: 25159481
[TBL] [Abstract][Full Text] [Related]
2. Expression of cyclin D2, P53, Rb and ATM cell cycle genes in brain tumors.
Kheirollahi M; Mehr-Azin M; Kamalian N; Mehdipour P
Med Oncol; 2011 Mar; 28(1):7-14. PubMed ID: 20077038
[TBL] [Abstract][Full Text] [Related]
3.
Karamat U; Ejaz S; Hameed Y
Genet Test Mol Biomarkers; 2021 Apr; 25(4):263-275. PubMed ID: 33877897
[No Abstract] [Full Text] [Related]
4. Methylation, expression, and mutation analysis of the cell cycle control genes in human brain tumors.
Yin D; Xie D; Hofmann WK; Miller CW; Black KL; Koeffler HP
Oncogene; 2002 Nov; 21(54):8372-8. PubMed ID: 12447702
[TBL] [Abstract][Full Text] [Related]
5. Importance of ATM gene as a susceptible trait: predisposition role of D1853N polymorphism in breast cancer.
Mehdipour P; Mahdavi M; Mohammadi-Asl J; Atri M
Med Oncol; 2011 Sep; 28(3):733-7. PubMed ID: 20396981
[TBL] [Abstract][Full Text] [Related]
6. Methylation of the ataxia telangiectasia mutated gene (ATM) promoter as a radiotherapy outcome biomarker in patients with hepatocellular carcinoma.
Yan X; Wu T; Tang M; Chen D; Huang M; Zhou S; Zhang H; Yang X; Li G
Medicine (Baltimore); 2020 Jan; 99(4):e18823. PubMed ID: 31977876
[TBL] [Abstract][Full Text] [Related]
7. Telomere length, ATM mutation status and cancer risk in Ataxia-Telangiectasia families.
Renault AL; Mebirouk N; Cavaciuti E; Le Gal D; Lecarpentier J; d'Enghien CD; Laugé A; Dondon MG; Labbé M; Lesca G; Leroux D; Gladieff L; Adenis C; Faivre L; Gilbert-Dussardier B; Lortholary A; Fricker JP; Dahan K; Bay JO; Longy M; Buecher B; Janin N; Zattara H; Berthet P; Combès A; Coupier I; ; Hall J; Stoppa-Lyonnet D; Andrieu N; Lesueur F
Carcinogenesis; 2017 Oct; 38(10):994-1003. PubMed ID: 28981872
[TBL] [Abstract][Full Text] [Related]
8. Three-hit hypothesis in astrocytoma: tracing the polymorphism D1853N in ATM gene through a pedigree of the proband affected with primary brain tumor.
Mehdipour P; Habibi L; Mohammadi-Asl J; Kamalian N; Mehr Azin M
J Cancer Res Clin Oncol; 2008 Nov; 134(11):1173-80. PubMed ID: 18465141
[TBL] [Abstract][Full Text] [Related]
9. ATM mediates pRB function to control DNMT1 protein stability and DNA methylation.
Shamma A; Suzuki M; Hayashi N; Kobayashi M; Sasaki N; Nishiuchi T; Doki Y; Okamoto T; Kohno S; Muranaka H; Kitajima S; Yamamoto K; Takahashi C
Mol Cell Biol; 2013 Aug; 33(16):3113-24. PubMed ID: 23754744
[TBL] [Abstract][Full Text] [Related]
10. Aberrant promoter hypermethylation of p16, survivin, and retinoblastoma in gastric cancer.
Guo L; Huang C; Ji QJ
Bratisl Lek Listy; 2017; 118(3):164-168. PubMed ID: 28319413
[TBL] [Abstract][Full Text] [Related]
11. Replication independent DNA double-strand break retention may prevent genomic instability.
Kongruttanachok N; Phuangphairoj C; Thongnak A; Ponyeam W; Rattanatanyong P; Pornthanakasem W; Mutirangura A
Mol Cancer; 2010 Mar; 9():70. PubMed ID: 20356374
[TBL] [Abstract][Full Text] [Related]
12. ATM expression is attenuated by promoter hypermethylation in human ovarian endometriotic stromal cells.
Hirakawa T; Nasu K; Aoyagi Y; Takebayashi K; Zhu R; Narahara H
Mol Hum Reprod; 2019 Jun; 25(6):295-304. PubMed ID: 30869775
[TBL] [Abstract][Full Text] [Related]
13. O6-methylguanine DNA methyltransferase gene promoter methylation status in gliomas and its correlation with other molecular alterations: first Indian report with review of challenges for use in customized treatment.
Jha P; Suri V; Jain A; Sharma MC; Pathak P; Jha P; Srivastava A; Suri A; Gupta D; Chosdol K; Chattopadhyay P; Sarkar C
Neurosurgery; 2010 Dec; 67(6):1681-91. PubMed ID: 21107199
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Promoter Methylation of RASSF1A and ATM in Peripheral Blood of Breast Cancer Patients and Healthy Control Individuals.
Cao X; Tang Q; Holland-Letz T; Gündert M; Cuk K; Schott S; Heil J; Golatta M; Sohn C; Schneeweiss A; Burwinkel B
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562656
[TBL] [Abstract][Full Text] [Related]
15. Correlation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumors.
Kuo LT; Kuo KT; Lee MJ; Wei CC; Scaravilli F; Tsai JC; Tseng HM; Kuo MF; Tu YK
Int J Cancer; 2009 Jun; 124(12):2872-9. PubMed ID: 19330828
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional role of ATM/Tel1 kinase in genome stability: from the DNA damage response to telomere maintenance.
Di Domenico EG; Romano E; Del Porto P; Ascenzioni F
Biomed Res Int; 2014; 2014():787404. PubMed ID: 25247188
[TBL] [Abstract][Full Text] [Related]
17. Frequent alterations of MCPH1 and ATM are associated with primary breast carcinoma: clinical and prognostic implications.
Bhattacharya N; Mukherjee N; Singh RK; Sinha S; Alam N; Roy A; Roychoudhury S; Panda CK
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S424-32. PubMed ID: 23117476
[TBL] [Abstract][Full Text] [Related]
18. Methylation Status of the RIZ1 Gene Promoter in Human Glioma Tissues and Cell Lines.
Zhang C; Meng W; Wang J; Lu Y; Hu G; Hu L; Ma J
Cell Mol Neurobiol; 2017 Aug; 37(6):1021-1027. PubMed ID: 27757741
[TBL] [Abstract][Full Text] [Related]
19. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
[TBL] [Abstract][Full Text] [Related]
20. Telomere length and its correlation with gene mutations in chronic lymphocytic leukemia in a Korean population.
Song DY; Kim JA; Jeong D; Yun J; Kim SM; Lim K; Park SN; Im K; Choi S; Yoon SS; Lee DS
PLoS One; 2019; 14(7):e0220177. PubMed ID: 31335885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
